"label","id","uuid:ID","instanceType","description","text","name"
"","Objective_1","6c1b957b-b04e-42f9-9715-55d8ea05c6bc","Objective","Main objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","OBJ1"
"","Objective_2","6545351d-b10c-4c88-a6c1-df61ee09b7b9","Objective","Safety","To document the safety profile of the xanomeline TTS.","OBJ2"
"","Objective_3","8b2c6820-e2bd-4e63-835b-cfa7717cbdf0","Objective","Behaviour","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","OBJ3"
